IntegraGen's First-Half Revenues Climb 67 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – French biotech firm IntegraGen today announced that its first-half revenues increased 67 percent year over year driven by demand for its genomic services.

For the half-year, revenues rose to €2.5 million ($3.4 million) from €1.5 million a year ago, resulting in a 32 percent improvement in its net loss to €890,000, compared to €1.3 million a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.